Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback